Hikma Pharmaceuticals non-exec sells 5,700 shares
21st May 2013 15:52
Ronald Goode, a non-Executive Director of Hikma Pharmaceuticals, has disposed of 5,700 shares at 983.00p each. The £56,031 sale comes less than a week after the company upgraded its 2013 revenue growth forecast following a strong start to the year. In an announcment released May 16th, the group t
Read moreJPMorgan Claverhouse Investment Trust Declares Q2 Dividend Of 3.5P
29th Jul 2010 15:51
LONDON (Dow Jones)--JPMorgan Claverhouse Investment Trust PLC (JCH.LN) said Thursday it has declared a second quarter interim dividend of 3.50 pence per share for the year ending Dec. 31, 2010. -Shares at 1450 GMT unchanged at 418.5 pence, valuing the company at GBP233.4 million. -By Tapan P
Read moreJPMorgan Claver IT Buys 10,000 In Own Shares
24th Jun 2010 17:32
LONDON (Dow Jones)--JPMorgan Claverhouse Investment Trust Plc (JCH.LN), announced Thursday it purchased into its treasury 10,000 Ordinary shares at 394.00 pence per share. MAIN FACTS: -Shares closed Thursday at 396.75 pence. -By Zechariah Hemans, Dow Jones Newswires; 44-20-7842-9411; zec
Read moreJPMorgan Claver IT Buys 40,000 In Own Shares
22nd Jun 2010 17:34
LONDON (Dow Jones)--JPMorgan Claverhouse Investment Trust Plc (JCH.LN), it purchased into its Treasury 40,000 Ordinary shares at 405.4 pence per share. MAIN FACTS: -Shares closed Tuesday at 409 pence. -By Zechariah Hemans, Dow Jones Newswires; 44-20-7842-9411; [email protected]
Read moreJPMorgan Claverhouse Buys Back 9,000 Shares At 398.33P
15th Jun 2010 17:27
LONDON (Dow Jones)--JPMorgan Claverhouse IT PLC (JCH.LN) said Tuesday it has purchased into treasury 9,000 ordinary shares at 398.33 pence per share. MAIN FACTS: -Shares closed Tuesday at 405 pence. -By Tommy Stubbington, Dow Jones Newswires; 44-20-7842-9268; tommy.stubbington@dowjones.
Read more